Editorial

Most Recent

was born in Tel Aviv and came to the United States in 1975.

0 Comments

Top 5 Grouches of 2005

By | December 5, 2005

we discuss the issues that have had an impact on infrastructure and business in the life sciences. As ever, science marches on.

0 Comments

Vaccines are Back

By | November 21, 2005

The last time I wrote about vaccines was two years ago – November 17, 2003, to be precise.1 That editorial crackled with frustration about the status of the most effective health intervention that has ever been invented:"Vaccines are unattractive targets for industry, underappreciated from the public health perspective, underfunded by basic research organizations, and treated with suspicion by the public."It's a pleasure to report that, two years later, there are the beginnings of a remark

0 Comments

The Challenges Facing Neuroscience

By | November 7, 2005

Neuroscience is intellectually the broadest and most taxing field in life sciences, and technologically it is the most challenging.

1 Comment

Time for Rapid Rebuttal Technology

By | October 24, 2005

I hadn't realized until recently that the United States is in the grip of a mania.

0 Comments

Why We Need Institutional Repositories

By | October 10, 2005

It used to be that the record of scientific work was complete when it was all published in journals.

0 Comments

Let's Talk About This

By | September 26, 2005

How do scientists communicate, with one another and with the public?

0 Comments

Combating Malevolence

By | September 12, 2005

Whatever the entertainment and artistic merits of the movie "The Constant Gardener," released at the end of last month, the pharmaceutical industry could do without it.

0 Comments

Seven Cheers for Technology

By | August 29, 2005

In 1986, the year in which the automated DNA sequencer was invented, GenBank held a scant 9.6 million bases.

0 Comments

On Your Mark, Get Set, Blog!

By | August 1, 2005

The life sciences have been slow to embrace blogging.

0 Comments

Popular Now

  1. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. What Sensory Receptors Do Outside of Sense Organs
RayBiotech